PRISM

Trial description
A randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma
Contact name
Dr Kate Fife
Trial start date
Wednesday, June 6, 2018
Trial end date
Sunday, August 26, 2018
Trial tumour type
Kidney
Show on Radiotherapy
No